{"slug":"tesamorelin-statins","verification":{"valid":true,"entries":2,"head":"c2e13e8d7f60d3756d699f90972379012cf45459cbbd539526b0326a0a25c176"},"energy":{"passes":2,"tokens_in":26557,"tokens_out":3154,"tokens_total":29711,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"c2e13e8d7f60d3756d699f90972379012cf45459cbbd539526b0326a0a25c176"},"provenance":[{"ts":"2026-06-29T23:12:59.694Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Statins\nSlug: tesamorelin-statins\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Statins\",\"condition_key\":\"statins\",\"primary_peptide\":\"tesamorelin\",\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[\"statins\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Statins\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"You are reading about **Statins** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Statins** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"statins\",\"name\":\"Statins\",\"section_title\":\"Why Statins matters for you\",\"steps\":[\"**Drug:** Statins\",\"**What it does:** Lipid management; debated cognitive/muscle side effects in subset.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off ","response":"{\n  \"slug\": \"tesamorelin-statins\",\n  \"title\": \"Tesamorelin and Statins: Evidence on Visceral Fat, Lipids, and Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Statins\\n\\nStatins primarily manage blood lipids by inhibiting HMG-CoA reductase in the liver. This reduces circulating cholesterol and lowers cardiovascular risk in many people. For readers exploring this cross, the relevant layers include potential muscle effects in a subset of users, debated impacts on glucose handling or cognition in sensitive individuals, and ongoing visceral fat accumulation that statins do not directly target. \\n\\nIf your profile includes excess visceral adipose tissue, that tissue releases inflammatory signals and free fatty acids that can worsen metabolic stress. Statins address one pathway (hepatic cholesterol synthesis) but leave visceral fat reduction to diet, exercise, or other interventions. The condition persists when breakdown signals (inflammation from VAT) outrun repair processes in adipose and muscle tissue.\\n\\n## Why Tesamorelin might help you\\n\\n1. You are reading about **Statins** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nTesamorelin stimulates the growth hormone axis. In human trials this led to measurable reductions in visceral adipose tissue. If visceral fat contributes to your lipid or inflammatory burden while on statins, lowering that depot may reduce the metabolic load that statins alone do not touch. The pathway is indirect: less VAT often correlates with improved triglyceride and total cholesterol readings in the same studies.\\n\\nIf muscle recovery or lean mass maintenance matters alongside statin use, the same GH-axis stimulation preserved or slightly increased lean body mass in trial participants without worsening glucose control. This differs from simple suppression of cholester","tokens_in":26557,"tokens_out":3154,"cost":0,"prev":"genesis","hash":"3514d234e9f33192b91ae6f780957b3f3a830745ce268c6855e94dcd8e70ac5e"},{"ts":"2026-07-17T02:42:26.614Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-statins","response":"30 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3514d234e9f33192b91ae6f780957b3f3a830745ce268c6855e94dcd8e70ac5e","hash":"c2e13e8d7f60d3756d699f90972379012cf45459cbbd539526b0326a0a25c176"}]}